Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2025

Feb 18, 2025

30016_dirs_2025-02-18_abac9fe4-8340-4dbf-8b3e-6f023cab5fcd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2025-02-14

Reporting Person: MCKEON BRIAN P (EVP, CFO and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-14 Common Stock M 252 Acquired 31208.5926 Direct
2025-02-14 Common Stock M 303 Acquired 31511.5926 Direct
2025-02-14 Common Stock M 308 Acquired 31819.5926 Direct
2025-02-14 Common Stock M 299 Acquired 32118.5926 Direct
2025-02-14 Common Stock F 569 $444.53 Disposed 31549.5926 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-14 Restricted Stock Unit $ M 252 Disposed Common Stock (252) Direct
2025-02-14 Restricted Stock Unit $ M 303 Disposed Common Stock (303) Direct
2025-02-14 Restricted Stock Unit $ M 308 Disposed Common Stock (308) Direct
2025-02-14 Restricted Stock Unit $ M 299 Disposed Common Stock (299) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 18050 Indirect

Footnotes

F1: Includes a total of 25 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2024 and December 31, 2024.

F2: Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022.

F3: Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2023.

F4: Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2024.

F5: Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2025.